Advertisement
News
Subscribe to MDT Magazine News

Pierrel Research USA Launches Orablocâ„¢ a New Purer Articaine

May 10, 2011 11:36 am | by Bio-Medicine.Org | Comments

WAYNE, Pa., May 10, 2011 /- Pierrel Research USA, Inc. ( www.pierrel-research-usa.com ), a subsidiary of Pierrel SpA, the Italian-based, global pharmaceutical services company ( www.pierrel.it ), announces the US launch of Orabloc™ (Articaine hydrochloride 4% with epinephrine...

TOPICS:

American Imaging Management Named as Finalist for 2011 URAC Award for Best Practices in Health Care Consumer Empowerment and Protection

May 10, 2011 10:32 am | by Bio-Medicine.Org | Comments

CHICAGO, May 10, 2011 /- American Imaging Management (AIM) was selected as one of 20 finalists for the 2011 URAC Awards for Best Practices in Health Care Consumer Empowerment and Protection. URAC, the nation's leading accreditation organization, will honor the finalists during URAC's 12th...

TOPICS:

Mindray shares jump on 1Q profit boost

May 10, 2011 9:45 am | by The Associated Press | Comments

Shares of medical device maker Mindray Medical International Ltd. jumped Tuesday after the company reported a 4 percent boost in first-quarter profit and reaffirmed its growth outlook.The stock rose $2.73, or 9.9 percent, to $30.27 in afternoon trading. Shares have traded between $25 and $35.95...

Advertisement

RNA spurs melanoma development

May 10, 2011 9:37 am | by EurekAlert | Comments

(Sanford-Burnham Medical Research Institute) Researchers at Sanford-Burnham Medical Research Institute and the University of Queensland show that long, non-coding RNA (lncRNA) levels are altered in human melanoma. Their study, published online May 10 by the journal Cancer Research,...

TOPICS:

Surgical Care Affiliates Announces Investor Conference Call to Discuss 2011 First Quarter Results

May 10, 2011 9:35 am | by Bio-Medicine.Org | Comments

BIRMINGHAM, Ala., May 10, 2011 /- Surgical Care Affiliates ("SCA") today announced that it will host an investor conference call at 10:00 a.m. Central Time on Monday, May 16, 2011, to discuss its 2011 first quarter operating results. A 30-day replay will be available approximately an hour...

TOPICS:

NMT Medical, Inc. Sealed Bid Sale of its Intellectual Property to Take Place Friday, June 10, 2011 at Twelve O'Clock Noon

May 10, 2011 9:34 am | by Bio-Medicine.Org | Comments

WELLESLEY HILLS, Mass., May 10, 2011 /- On Friday, June 10, 2011 at twelve o'clock noon, NMT Medical, Inc. intellectual property, which has been assigned to Joseph F. Finn, Jr., C.P.A. ("Finn") of the firm Finn, Warnke & Gayton, LLP will be liquidated for the benefit of NMT Medical...

TOPICS:

83 Cases of Autism Associated with Childhood Vaccine Injury Compensated in Federal Vaccine Court

May 10, 2011 9:33 am | by Bio-Medicine.Org | Comments

WASHINGTON, May 10, 2011 /PRNewswire-USNewswire/ -- The following is being released by SafeMinds ( www.SafeMinds.org ): For over 20 years, the federal government has publicly denied a vaccine-autism link, while at the same time its Vaccine Injury Compensation Program (VICP) has been...

TOPICS:

Boston Scientific CEO will retire at year-end

May 10, 2011 8:45 am | by MARLEY SEAMAN - AP Health Writers - Associated Press | Comments

Medical device maker Boston Scientific Corp. announced Tuesday that its Chief Executive Ray Elliott will retire as president and CEO at the end of the year, after just over two years leading the company.Elliott's departure was unexpected and sent company shares tumbling more than 10 percent.The...

Advertisement

Myriad signs licensing deal for cancer tests

May 10, 2011 7:45 am | by The Associated Press | Comments

Molecular diagnostics company Myriad Genetics Inc. said Tuesday that it signed a deal to license technology for the early detection of cancer from Chronix Biomedical.Terms of the deal were not disclosed.Myriad, based in Salt Lake City, said it receives rights to sell tests for the early...

Micromet 1Q loss narrows on warrant gain

May 10, 2011 7:45 am | by The Associated Press | Comments

Cancer drug developer Micromet Inc. said Tuesday its first-quarter loss narrowed on a boost from the value of warrants.The company reported a net loss of $8.2 million, or 9 cents per share, in the three months that ended March 31. That compares with a net loss of $18.3 million, or 26 cents per...

Who gets treated where for colonoscopy, and how effective is that treatment?

May 10, 2011 7:37 am | by EurekAlert | Comments

(Digestive Disease Week) Research being presented at Digestive Disease Week continues to show the effectiveness of colonoscopy for the prevention and detection of colorectal cancer. However, studies show that patients in lower socioeconomic groups are less likely to receive care...

TOPICS:

Boston Scientific Announces Retirement of Ray Elliott as President and CEO Effective End of 2011

May 10, 2011 7:35 am | by Boston Scientific | Comments

Elliott to remain on Board as non-executive director

TOPICS:

Mayo Clinic researchers find new treatment for constipation

May 10, 2011 6:40 am | by EurekAlert | Comments

(Mayo Clinic) Constipation is definitely not a glamorous topic. In reality, it affects nearly 30 million Americans and costs more than $1 billion annually to evaluate and treat. While not often life threatening, the pain, bloating, discomfort, and straining associated with...

TOPICS:

First-ever Gamma Knife in Paris Offers New Treatment Options for Patients With Cancer and Other Brain Disorders

May 10, 2011 6:34 am | by Bio-Medicine.Org | Comments

PARIS, May 10, 2011 /- Groupe Hospitalier Pitie Salpetriere, a world-renowned teaching hospital, and among Europe's largest medical centers has continued its long tradition of excellence in neurosciences and its expertise in radiation therapy with the acquisition of Leksell Gamma...

TOPICS:

Bioness Inc. Receives FDA Clearance of Its NESS L300 Plus System

May 10, 2011 6:33 am | by Bio-Medicine.Org | Comments

VALENCIA, Calif., May 10, 2011 /- Bioness Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its NESS L300® Plus System. The device combines the Company's NESS L300® Foot Drop System with a thigh stimulation cuff, to...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading